While global cancer cases continue to rise around the world, the fight is personal not only for patients and their loved ones but also for the scientific community.
A Point of View by Dr. Roger Dansey, Head of MSD’s Oncology Late Stage Development Program
We are investing significant resources to develop innovative oncology medicines to help people living with cancer worldwide.
Celebrating a legacy of invention that continues to fuel our quest to cure.
Copyright © 2009-2016 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Kenilworth, NJ, USA All rights reserved.